These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1052 related items for PubMed ID: 24964928

  • 1. Common etiological factors of attention-deficit/hyperactivity disorder and suicidal behavior: a population-based study in Sweden.
    Ljung T, Chen Q, Lichtenstein P, Larsson H.
    JAMA Psychiatry; 2014 Aug; 71(8):958-64. PubMed ID: 24964928
    [Abstract] [Full Text] [Related]

  • 2. Attention-deficit/hyperactivity disorder and risk for substance use disorders in relatives.
    Skoglund C, Chen Q, Franck J, Lichtenstein P, Larsson H.
    Biol Psychiatry; 2015 May 15; 77(10):880-6. PubMed ID: 25457227
    [Abstract] [Full Text] [Related]

  • 3. Familial Liability for Eating Disorders and Suicide Attempts: Evidence From a Population Registry in Sweden.
    Yao S, Kuja-Halkola R, Thornton LM, Runfola CD, D'Onofrio BM, Almqvist C, Lichtenstein P, Sjölander A, Larsson H, Bulik CM.
    JAMA Psychiatry; 2016 Mar 15; 73(3):284-91. PubMed ID: 26764185
    [Abstract] [Full Text] [Related]

  • 4. Familial aggregation of attention-deficit/hyperactivity disorder.
    Chen Q, Brikell I, Lichtenstein P, Serlachius E, Kuja-Halkola R, Sandin S, Larsson H.
    J Child Psychol Psychiatry; 2017 Mar 15; 58(3):231-239. PubMed ID: 27545745
    [Abstract] [Full Text] [Related]

  • 5. Family history of suicidal behavior and mood disorders in probands with mood disorders.
    Mann JJ, Bortinger J, Oquendo MA, Currier D, Li S, Brent DA.
    Am J Psychiatry; 2005 Sep 15; 162(9):1672-9. PubMed ID: 16135627
    [Abstract] [Full Text] [Related]

  • 6. Shared familial risk factors between attention-deficit/hyperactivity disorder and overweight/obesity - a population-based familial coaggregation study in Sweden.
    Chen Q, Kuja-Halkola R, Sjölander A, Serlachius E, Cortese S, Faraone SV, Almqvist C, Larsson H.
    J Child Psychol Psychiatry; 2017 Jun 15; 58(6):711-718. PubMed ID: 28121008
    [Abstract] [Full Text] [Related]

  • 7. Completed suicide, ideation and attempt in attention deficit hyperactivity disorder.
    Impey M, Heun R.
    Acta Psychiatr Scand; 2012 Feb 15; 125(2):93-102. PubMed ID: 22118301
    [Abstract] [Full Text] [Related]

  • 8. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission.
    Antshel KM, Kaul P, Biederman J, Spencer TJ, Hier BO, Hendricks K, Faraone SV.
    J Clin Psychiatry; 2013 Mar 15; 74(3):e197-204. PubMed ID: 23561240
    [Abstract] [Full Text] [Related]

  • 9. [Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence].
    Keresztény A, Dallos G, Miklósi M, Róka A, Gádoros J, Balázs J.
    Psychiatr Hung; 2012 Mar 15; 27(3):165-73. PubMed ID: 22781541
    [Abstract] [Full Text] [Related]

  • 10. Childhood predictors of completed and severe suicide attempts: findings from the Finnish 1981 Birth Cohort Study.
    Sourander A, Klomek AB, Niemelä S, Haavisto A, Gyllenberg D, Helenius H, Sillanmäki L, Ristkari T, Kumpulainen K, Tamminen T, Moilanen I, Piha J, Almqvist F, Gould MS.
    Arch Gen Psychiatry; 2009 Apr 15; 66(4):398-406. PubMed ID: 19349309
    [Abstract] [Full Text] [Related]

  • 11. Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort.
    Cesta CE, Månsson M, Palm C, Lichtenstein P, Iliadou AN, Landén M.
    Psychoneuroendocrinology; 2016 Nov 15; 73():196-203. PubMed ID: 27513883
    [Abstract] [Full Text] [Related]

  • 12. Attention-deficit/hyperactivity disorder symptoms and suicidal behavior in adult psychiatric outpatients.
    Stickley A, Tachimori H, Inoue Y, Shinkai T, Yoshimura R, Nakamura J, Morita G, Nishii S, Tokutsu Y, Otsuka Y, Egashira K, Inoue M, Kubo T, Tesen H, Takashima N, Tominaga H, Koyanagi A, Kamio Y.
    Psychiatry Clin Neurosci; 2018 Sep 15; 72(9):713-722. PubMed ID: 29845681
    [Abstract] [Full Text] [Related]

  • 13. Do borderline personality disorder and attention-deficit/hyperactivity disorder co-aggregate in families? A population-based study of 2 million Swedes.
    Kuja-Halkola R, Lind Juto K, Skoglund C, Rück C, Mataix-Cols D, Pérez-Vigil A, Larsson J, Hellner C, Långström N, Petrovic P, Lichtenstein P, Larsson H.
    Mol Psychiatry; 2021 Jan 15; 26(1):341-349. PubMed ID: 30323291
    [Abstract] [Full Text] [Related]

  • 14. Association of Psychiatric Comorbidity With the Risk of Premature Death Among Children and Adults With Attention-Deficit/Hyperactivity Disorder.
    Sun S, Kuja-Halkola R, Faraone SV, D'Onofrio BM, Dalsgaard S, Chang Z, Larsson H.
    JAMA Psychiatry; 2019 Nov 01; 76(11):1141-1149. PubMed ID: 31389973
    [Abstract] [Full Text] [Related]

  • 15. Familial co-aggregation of attention-deficit/hyperactivity disorder and autoimmune diseases: a cohort study based on Swedish population-wide registers.
    Hegvik TA, Chen Q, Kuja-Halkola R, Klungsøyr K, Butwicka A, Lichtenstein P, Almqvist C, Faraone SV, Haavik J, Larsson H.
    Int J Epidemiol; 2022 Jun 13; 51(3):898-909. PubMed ID: 34379767
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Attention-deficit/hyperactivity disorder and clinically diagnosed obesity in adolescence and young adulthood: a register-based study in Sweden.
    Chen Q, Hartman CA, Kuja-Halkola R, Faraone SV, Almqvist C, Larsson H.
    Psychol Med; 2019 Aug 13; 49(11):1841-1849. PubMed ID: 30220266
    [Abstract] [Full Text] [Related]

  • 20. Suicide risk in attention-deficit/hyperactivity disorder.
    Giupponi G, Giordano G, Maniscalco I, Erbuto D, Berardelli I, Conca A, Lester D, Girardi P, Pompili M.
    Psychiatr Danub; 2018 Mar 13; 30(1):2-10. PubMed ID: 29546852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.